Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells

Details for Australian Patent Application No. 2005276145 (hide)

Owner Engeneic Molecular Delivery Pty Ltd

Inventors MacDiarmid, Jennifer; Brahmbhatt, Himanshu

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005276145

PCT Pub. Number WO2006/021894

Priority 60/604,433 26.08.04 US

Filing date 25 August 2005

Wipo publication date 2 March 2006

Acceptance publication date 27 May 2010

International Classifications

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/021894 Priority application(s): WO2006/021894

20 May 2010 Alteration of Name

  The name of the applicant has been altered to Engeneic Molecular Delivery Pty Ltd

27 May 2010 Application Accepted

  Published as AU-B-2005276145

9 September 2010 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 24 Aug 2010. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000

6 January 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 24 Aug 2010

13 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005276189-Ear tag element and methods for producing an ear tag element

2005276144-Pharmaceutical compositions comprising inhibitors of iron transport, and method of identifying iron transport inhibitors, FN Staphylococcus aureus